ATE408411T1 - Verwendung von polysaccharid-derivaten als antiinfektive substanzen - Google Patents
Verwendung von polysaccharid-derivaten als antiinfektive substanzenInfo
- Publication number
- ATE408411T1 ATE408411T1 AT03729214T AT03729214T ATE408411T1 AT E408411 T1 ATE408411 T1 AT E408411T1 AT 03729214 T AT03729214 T AT 03729214T AT 03729214 T AT03729214 T AT 03729214T AT E408411 T1 ATE408411 T1 AT E408411T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- group
- alpha
- alkyl
- polysaccharide derivative
- Prior art date
Links
- 150000004676 glycans Chemical class 0.000 title abstract 5
- 229920001282 polysaccharide Polymers 0.000 title abstract 5
- 239000005017 polysaccharide Substances 0.000 title abstract 5
- 230000002924 anti-infective effect Effects 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- 229920002472 Starch Polymers 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 4
- 235000019698 starch Nutrition 0.000 abstract 4
- 239000008107 starch Substances 0.000 abstract 4
- 208000035473 Communicable disease Diseases 0.000 abstract 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 2
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 150000001450 anions Chemical group 0.000 abstract 1
- 150000004820 halides Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000001453 quaternary ammonium group Chemical group 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/719—Pullulans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/721—Dextrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10200717A DE10200717A1 (de) | 2002-01-10 | 2002-01-10 | Verwendung von Polysaccharid-Derivaten als antiinfektive Substanzen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE408411T1 true ATE408411T1 (de) | 2008-10-15 |
Family
ID=7711838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03729214T ATE408411T1 (de) | 2002-01-10 | 2003-01-10 | Verwendung von polysaccharid-derivaten als antiinfektive substanzen |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7297687B2 (enExample) |
| EP (1) | EP1465640B8 (enExample) |
| JP (1) | JP4452777B2 (enExample) |
| KR (1) | KR100913301B1 (enExample) |
| CN (1) | CN1615141B (enExample) |
| AT (1) | ATE408411T1 (enExample) |
| AU (1) | AU2003210125B2 (enExample) |
| BR (1) | BRPI0306851A8 (enExample) |
| CA (1) | CA2472586C (enExample) |
| DE (2) | DE10200717A1 (enExample) |
| ES (1) | ES2314205T3 (enExample) |
| MX (1) | MXPA04006673A (enExample) |
| NO (1) | NO20043265L (enExample) |
| PL (1) | PL206600B1 (enExample) |
| RU (1) | RU2332221C2 (enExample) |
| WO (1) | WO2003057227A1 (enExample) |
| ZA (1) | ZA200405400B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1635661T3 (pl) * | 2003-06-13 | 2011-02-28 | Wadstroem Torkel | Wyrób dla celów absorpcyjnych |
| CN100469707C (zh) * | 2005-03-11 | 2009-03-18 | 中国石化北京燕化石油化工股份有限公司 | 一种高浊高铁循环冷却水的处理方法 |
| KR101278106B1 (ko) * | 2011-03-03 | 2013-06-24 | 이원실 | 이온성 액체를 이용한 셀룰로오스계 고분자 항균제의 제조방법 |
| WO2013132061A1 (de) | 2012-03-09 | 2013-09-12 | Friedrich-Schiller-Universität Jena | Di- und multifunktional amin-modifizierte oligo- und polysaccharidderivate als antiinfektive substanzen und deren verwendung |
| US20170360040A1 (en) * | 2014-12-02 | 2017-12-21 | B.G. Negev Technologies And Applications Ltd., At Ben-Gurion University | Modified polysaccharides for use as anti-microbial agents |
| FR3064473B1 (fr) * | 2017-04-03 | 2021-02-12 | Basf Beauty Care Solutions France Sas | Ingredient protecteur de l'equilibre de la flore microbienne cutanee et/ou mucosale |
| US20210275434A1 (en) * | 2018-07-20 | 2021-09-09 | Shiseido Company, Ltd. | Virus inactivating agent |
| CN115260320B (zh) * | 2021-04-30 | 2023-05-05 | 中国科学院化学研究所 | 离子型多糖衍生物用作防冰涂层材料的应用 |
| KR102559540B1 (ko) | 2022-09-19 | 2023-07-25 | 문건희 | 토류벽시스템용 토류벽체 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60203265A (ja) * | 1984-03-28 | 1985-10-14 | ダイセル化学工業株式会社 | 抗血液凝固性高分子材料 |
| DE3711680A1 (de) | 1987-04-07 | 1988-10-27 | Hoechst Ag | Waessrige biozide kationische kunststoffdispersionen und deren verwendung als fungizide, bakterizide und algizide ausruestungsmittel |
| DE3720555A1 (de) * | 1987-06-22 | 1989-01-05 | Henkel Kgaa | Verwendung von unloeslichen, polyfunktionellen quartaeren ammoniumverbindungen zur adsorptiven bindung von mikroorganismen |
| IT1231168B (it) * | 1989-07-21 | 1991-11-22 | Texcontor Ets | Copolimeri saccaridici aventi attivita' antibatterica. |
| JPH0457969A (ja) * | 1990-06-27 | 1992-02-25 | Unitika Ltd | 抗菌性布帛の製造方法 |
| US5731259A (en) | 1991-05-03 | 1998-03-24 | Societa Consortile Ricerche Angelini S.P.A. | Cationic polysaccharides |
| IT1249309B (it) * | 1991-05-03 | 1995-02-22 | Faricerca Spa | Polisaccaridi di tipo cationico |
| GB2262531B (en) * | 1991-12-17 | 1995-12-06 | Erba Carlo Spa | Antiviral sulphated polysaccharides |
| JPH05295002A (ja) * | 1992-04-23 | 1993-11-09 | Nichiden Kagaku Kk | 抗菌性澱粉、水溶性多糖類及びその製造方法 |
| ZA947572B (en) * | 1993-09-29 | 1995-09-28 | Hampton Roads Medical College | Contraceptive compositions |
| RU2098114C1 (ru) * | 1995-02-03 | 1997-12-10 | Музыка Владислав Иванович | Препарат, воздействующий на функциональную активность клеток эукариот и прокариот |
| JPH10155898A (ja) * | 1996-11-26 | 1998-06-16 | Toyobo Co Ltd | 抗菌性付与抗血栓性材料 |
| US6096291A (en) * | 1996-12-27 | 2000-08-01 | Biovector Therapeutics, S.A. | Mucosal administration of substances to mammals |
| US6306835B1 (en) | 1997-09-23 | 2001-10-23 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Biocidal chitosan derivatives |
| JP3961714B2 (ja) | 1998-04-09 | 2007-08-22 | ナショナル スターチ アンド ケミカル インベストメント ホールディング コーポレイション | 毛髪化粧用組成物 |
| AU6473499A (en) * | 1998-10-29 | 2000-05-22 | Ciba Specialty Chemicals Holding Inc. | Incorporation of organic anti-microbials into fibres during a fibre spinning process |
-
2002
- 2002-01-10 DE DE10200717A patent/DE10200717A1/de not_active Withdrawn
-
2003
- 2003-01-10 JP JP2003557585A patent/JP4452777B2/ja not_active Expired - Fee Related
- 2003-01-10 AT AT03729214T patent/ATE408411T1/de not_active IP Right Cessation
- 2003-01-10 DE DE50310510T patent/DE50310510D1/de not_active Expired - Lifetime
- 2003-01-10 BR BRPI0306851A patent/BRPI0306851A8/pt not_active IP Right Cessation
- 2003-01-10 WO PCT/DE2003/000095 patent/WO2003057227A1/de not_active Ceased
- 2003-01-10 PL PL370887A patent/PL206600B1/pl not_active IP Right Cessation
- 2003-01-10 AU AU2003210125A patent/AU2003210125B2/en not_active Ceased
- 2003-01-10 RU RU2004124389/15A patent/RU2332221C2/ru not_active IP Right Cessation
- 2003-01-10 EP EP03729214A patent/EP1465640B8/de not_active Expired - Lifetime
- 2003-01-10 MX MXPA04006673A patent/MXPA04006673A/es active IP Right Grant
- 2003-01-10 CA CA2472586A patent/CA2472586C/en not_active Expired - Fee Related
- 2003-01-10 US US10/500,807 patent/US7297687B2/en not_active Expired - Fee Related
- 2003-01-10 CN CN038021072A patent/CN1615141B/zh not_active Expired - Fee Related
- 2003-01-10 ES ES03729214T patent/ES2314205T3/es not_active Expired - Lifetime
- 2003-01-10 KR KR1020047010731A patent/KR100913301B1/ko not_active Expired - Fee Related
-
2004
- 2004-07-07 ZA ZA2004/05400A patent/ZA200405400B/en unknown
- 2004-08-04 NO NO20043265A patent/NO20043265L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1465640B1 (de) | 2008-09-17 |
| US7297687B2 (en) | 2007-11-20 |
| JP4452777B2 (ja) | 2010-04-21 |
| MXPA04006673A (es) | 2004-11-10 |
| DE50310510D1 (de) | 2008-10-30 |
| ES2314205T3 (es) | 2009-03-16 |
| KR20040079415A (ko) | 2004-09-14 |
| PL206600B1 (pl) | 2010-08-31 |
| JP2005519057A (ja) | 2005-06-30 |
| US20050054609A1 (en) | 2005-03-10 |
| RU2332221C2 (ru) | 2008-08-27 |
| EP1465640B8 (de) | 2009-04-01 |
| CN1615141A (zh) | 2005-05-11 |
| AU2003210125B2 (en) | 2008-01-24 |
| CA2472586A1 (en) | 2003-07-17 |
| ZA200405400B (en) | 2005-11-30 |
| AU2003210125A1 (en) | 2003-07-24 |
| WO2003057227A1 (de) | 2003-07-17 |
| EP1465640A1 (de) | 2004-10-13 |
| KR100913301B1 (ko) | 2009-08-26 |
| PL370887A1 (en) | 2005-05-30 |
| NO20043265L (no) | 2004-08-04 |
| RU2004124389A (ru) | 2005-05-10 |
| BRPI0306851A8 (pt) | 2017-04-25 |
| DE10200717A1 (de) | 2003-07-31 |
| CA2472586C (en) | 2011-03-15 |
| BRPI0306851A2 (pt) | 2016-11-16 |
| CN1615141B (zh) | 2013-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0507984A (pt) | composto ou um sal do mesmo, processo para produzir um composto, medicamento, métodos para antagonizar angiotensina ii em um mamìfero, para melhorar a resistência de insulina em um mamìfero e para prevenir ou tratar doenças circulatórias em um mamìfero, e, uso do composto | |
| DE60103995D1 (de) | Perzychinin, verfahren zu seiner herstellung und seine verwendung als pharmazeutisches produkt | |
| BRPI0406427B8 (pt) | processo para a preparação de roflumilast | |
| HRP20041042A2 (hr) | Novi supstituirani derivati sulfamata kao antikonvulzivi | |
| CY1106786T1 (el) | Παραγωγα ν-[ετεροαρυλο(πιπεριδινο-2-υλο)μεθυλο]βενζαμιδιου, η διαδικασια παρασκευης τους και η εφαρμογη τους στη θεραπευτικη | |
| MXPA05010712A (es) | Derivados de quinolin-2-ona para el tratamiento de enfermedades de las vias respiratorias. | |
| DE602004024880D1 (de) | Azetidincarboxamid-derivate zur verwendung zur behandlung von cb1-rezeptor-vermittelten krankheiten | |
| NO20075726L (no) | Fremgangsmate for syntese av 6-alkylaminokinolinderivater | |
| NO985864L (no) | Nye anti-virale forbindelser | |
| MY136686A (en) | Salt forms of 3-(4-bromo-2,6-difluoro-benzyloxy)-5-[3-(4-pyrrolidin-1-yl-butyl)-ureido]-isothiazole-4-carboxylic acid amide and method of production | |
| ATE408411T1 (de) | Verwendung von polysaccharid-derivaten als antiinfektive substanzen | |
| IS2367B (is) | Imídasólafleiður til að stilla natríumgöng | |
| SE9903894D0 (sv) | Novel compounds | |
| DK1513800T3 (da) | Benzoylureido-kanelsyrederivater, fremgangsmåde til deres anvendelse | |
| DE50311923D1 (de) | Harnstoff- und urethan-substituierte acylharnstoffe, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
| FR2847899B1 (fr) | Derives d'indole-3-carboxamide, leur preparation et leur application en therapeutique | |
| NO20050270L (no) | Nye forbindelser, deres anvendelse og fremstilling | |
| NO20044881L (no) | Acyl-3-karboksyfenylureaderivater, fremstillingsfremgangsmate og anvendelse derav | |
| ATE421961T1 (de) | Piperidinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzung zur behandlung von alzheimer-krankheit, die diese derivate enthält | |
| NO20054418L (no) | Substituert benzoylureidopyridylpiperidin- og -pyrrolidinkarboksylsyrederivater, deres fremstilling og anvendelse | |
| DE502004009016D1 (de) | Verwendung von chinaldin-und naphthalinderivaten als kristallisationsmodifikatoren | |
| CY1109717T1 (el) | Παραγωγα 5-πυριδινυλιο-1-αζαδικυκλο[3.2.1]οκτανιο, μεθοδος παρασκευης και η εφαρμογη τους στη θεραπευτικη | |
| DE60224509D1 (de) | Imidazolderivate verwendbar als histamin h3 rezeptorliganden | |
| BRPI0410353A (pt) | composto, uso de um composto, composição farmacêutica, métodos para as terapias da dor e da ansiedade em um animal de sangue quente, e, processo para preparar um composto | |
| NO20053876L (no) | Karbonylaminosubstituerte acylfenylurederivater, fremgangsmate for deres fremstilling samt anvendelse derav |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |